-
Mashup Score: 2Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0BTK inhibitors for B-cell malignancies: managing and improving class-driven adverse events - 3 year(s) ago
Bruton’s tyrosine kinase (BTK) inhibitors fulfill an increasingly important role in the treatment of patients with B-cell malignancies including chronic lymphocytic leukemia (CLL) and other subtypes of non-Hodgkin lymphoma (NHL), offering the potential for patients to receive chemotherapy-free treatment regimens. However, the incidence of treatment-related adverse events (TRAEs) associated with…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The MPN Sessions: highlights from EHA and ASCO 2021 - 3 year(s) ago
Over the past decade there has been a vast increase in the number of clinical trials taking place in the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0EMJ Hematology 9.1 2021 - European Medical Journal - 3 year(s) ago
EMJ Hematology reviews the European Hematology Association (EHA) 2021 Virtual Congress as well as featuring the latest research.
Source: European Medical JournalCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Our new issue of our Hematology eJournal is here! Read on for valuable research insights and fascinating comprehensive reviews, alongside our coverage of the insights and breaking news from the recent @EHA_Hematology Virtual Congress. https://t.co/AkbGPSC1dN #EHA21 #Hematology https://t.co/ltKffGKo2t
-
-
Mashup Score: 1Myeloma Sessions: Post-EHA/ASCO 2021 - 3 year(s) ago
Noopur Raje: Welcome to the Myeloma Session from VJHemOnc. It is my great pleasure to welcome a fantastic panel for a discussion on the recently concluded ASCO and EHA meetings. We’re going to be talking all myeloma, from new diagnosis to some of the new and exciting things we have in the myeloma space. And to discuss all of this, I have the pleasure of inviting Dr Katja Weisel, she is the Deputy…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Speaker: Prof. Mohamad Mohty Dr. Mohamad Mohty is a full Professor of Hematology and head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital and Sorbonne University in Paris, France. He obtained his medical degree from the University of Montpellier, France, and PhD from the University of Marseille, France. He is also head of a translational research team (Inserm) at…
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Not long until our post-EHA/ICML #LymphomaSession with @gilles_salles @niravshahmd Ulrich Jäger and Stephen Ansell! 🗓 Thurs 29 July at 7pm CEST/6pm BST/1pm EDT📊 Don’t miss your chance to register: https://t.co/4amTZ8Tzdg @VJHemOnc #VJSessions #Lymsm #Lymphoma #EHA21 #16ICML https://t.co/mJ3RP6XURb